Clinical Trials Logo

Clinical Trial Summary

This is a prospective, single-group clinical study. The objective is to evaluate the safety and efficacy of focal pulse ablation system in the treatment of typical atrial flutter.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06157437
Study type Interventional
Source Hangzhou Dinova EP Technology Co., Ltd
Contact Haitao Yang
Phone +8637158680341
Email dinova_ep@dnaeps.com
Status Not yet recruiting
Phase N/A
Start date December 2023
Completion date June 2024

See also
  Status Clinical Trial Phase
Withdrawn NCT04434599 - Fluoroscopic, Contact Force and Local Impedance With Ultra-high Density Mapping Guided Radiofrequency Ablation Comparison for cavoTricuspid Isthmus dependenT Atrial fluttER: the FLUTTER Study N/A
Recruiting NCT05777850 - High-Power Short-Duration Radiofrequency Ablation in Patients With Typical Atrial Flutter N/A
Completed NCT01401361 - Atrial Flutter Ablation With Contact Therapy Cool Path Ablation System Along With EnSite Velocity Contact System Phase 3
Completed NCT00984204 - Clinical Evaluation of Therapy™ Cool Path™ Duo Cardiac Ablation System for the Treatment of Typical Atrial Flutter (AFL) Phase 3
Withdrawn NCT01710150 - Pulmonary Vein Isolation To Reduce Future Risk Of Atrial Fibrillation In Patients Undergoing Typical Flutter N/A
Completed NCT01408485 - Therapy™ Cool Flex™ Irrigated Ablation System for Typical Atrial Flutter N/A
Completed NCT04658940 - AcQBlate Force Sensing Ablation System US IDE for Atrial Flutter (AcQForce Flutter) N/A
Recruiting NCT00750711 - Typical Flutter Ablation:A Comparison of 4 mm Versus 2 mm Irrigated cathéters N/A
Recruiting NCT03867266 - Typical Atrial Flutter, Ablation Index and Point by Point Ablation
Recruiting NCT04657055 - AcQBlate Force Sensing Ablation System EU Study for Atrial Flutter (AcQForce Flutter-EU) N/A